Lv2
170 积分 2024-12-10 加入
Targeting ACSLs to modulate ferroptosis and cancer immunity
1个月前
已完结
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
1个月前
已完结
Novel Macrocyclic NLRP3 Inhibitors
1个月前
已完结
Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement
1个月前
已完结
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF: The HuMAIN-HFpEF Randomized Clinical Trial
2个月前
已完结
New and future heart failure drugs
2个月前
已完结
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
2个月前
已完结
Metabolic dysfunction-associated steatohepatitis treatment: spotlight on the latest hepatoprotective drugs
2个月前
已关闭
Small Molecule Drug Discovery: Methods, Molecules and Applications
2个月前
已完结
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
2个月前
已完结
皖公网安备34019202002308
